18F-Fluciclovine PET/CT A Potential Imaging Biomarker for the Evaluation of Multiple Myeloma

被引:1
|
作者
Marcus, Charles [1 ]
Schuster, David M. [1 ]
Tajmir, Shahein Holmes [1 ]
机构
[1] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Div Nucl Med & Mol Imaging, Atlanta, GA USA
关键词
F-18-fluciclovine; multiple myeloma; PET/CT; prostate cancer; POSITRON-EMISSION-TOMOGRAPHY;
D O I
10.1097/RLU.0000000000004271
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Incidental concomitant second primary malignancy may be detected on PET/CT imaging. We present an F-18-fluciclovine PET/CT of a patient undergoing evaluation of biochemically recurrent prostate cancer with incidental radiotracer uptake within lytic osseous lesions confirmed to be multiple myeloma. We present the F-18-fluciclovine PET/CT images of an 83-year-old man with prostate cancer treated in 2005 who presented with back pain and a CT scan revealing multiple lytic osseous lesions concerning for metastases versus a plasma cell neoplasm. Prostate-specific antigen at the time of evaluation was 0.1 ng/mL.
引用
收藏
页码:E613 / E615
页数:3
相关论文
共 50 条
  • [31] 18F-fluciclovine (Axumin) PET/CT detecting occult bone metastasis
    Nepal, Pankaj
    Rodrigue, Paul
    Olsavsky, Thomas
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2020, 51 (01):
  • [32] Gastrointestinal Stromal Tumor Incidentally Detected on 18F-Fluciclovine PET/CT
    Raghavan, Kesav
    Flavell, Robert R.
    Westphalen, Antonio C.
    Behr, Spencer C.
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (04) : 345 - 347
  • [33] 18F-Fluciclovine PET Imaging of Glutaminase Inhibition in Breast Cancer Models
    Zhou, Rong
    Choi, Hoon
    Cao, Jianbo
    Pantel, Austin
    Gupta, Mamta
    Lee, Hsiaoju S.
    Mankoff, David
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (01) : 131 - 136
  • [34] 18F-Fluciclovine PET in Recurrent Prostate Cancer
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (04) : 17N - 17N
  • [35] Prostate Cancer Imaging with 18F-Fluciclovine
    Savir-Baruch, Bital
    Schuster, David M.
    PET CLINICS, 2022, 17 (04) : 607 - 620
  • [36] Characterising 18F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging
    N. P. Scott
    E. J. Teoh
    H. Flight
    B. E. Jones
    J. Niederer
    L. Mustata
    G. M. MacLean
    P. G. Roy
    D. D. Remoundos
    C. Snell
    C. Liu
    F. V. Gleeson
    A. L. Harris
    S. R. Lord
    D. R. McGowan
    British Journal of Cancer, 2022, 126 : 598 - 605
  • [37] Characterising 18F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging
    Scott, N. P.
    Teoh, E. J.
    Flight, H.
    Jones, B. E.
    Niederer, J.
    Mustata, L.
    MacLean, G. M.
    Roy, P. G.
    Remoundos, D. D.
    Snell, C.
    Liu, C.
    Gleeson, F., V
    Harris, A. L.
    Lord, S. R.
    McGowan, D. R.
    BRITISH JOURNAL OF CANCER, 2022, 126 (04) : 598 - 605
  • [38] Initial Experience with the Radiotracer 18F-Fluciclovine PET/CT in Ovarian Cancer
    Tina M. Buehner
    Margaret Liotta
    Ronald K. Potkul
    Robert H. Wagner
    Bital Savir-Baruch
    Molecular Imaging and Biology, 2024, 26 : 45 - 52
  • [39] Correction to: 18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors
    Laure Michaud
    B. J. Beattie
    T. Akhurst
    M. Dunphy
    P. Zanzonico
    R. Finn
    A. Mauguen
    H. Schöder
    W. A. Weber
    A. B. Lassman
    R. Blasberg
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 (1) : 4 - 4
  • [40] Complementary Role of 18F-Fluciclovine PET/CT and 18F-NaF PET/CT in Detecting Prostate Cancer Metastasis
    Xu, Feng
    Liu, Frank
    Chen, Wen
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (04) : 330 - 331